Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 5Completed 3Active not recruiting 3Terminated 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 5Breast 3Tumor-Agnostic 1Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Ovarian Neoplasms 1Brenner Tumor 1

Interventions

Paclitaxel 69Carboplatin 66Cisplatin 36pembrolizumab 34Gemcitabine 24liposomal doxorubicin 23Cyclophosphamide 23Topotecan 22Bevacizumab 20Taxes 14Docetaxel 13niraparib 12Nivolumab 12olaparib 10fludarabine 10Doxorubicin 9Surveys and Questionnaires 8Radiotherapy 8Oxaliplatin 8aldesleukin 7Filgrastim 7rucaparib 6oregovomab 6fludarabine phosphate 6durvalumab 6avelumab 6Interleukin-2 6Hyperthermic Intraperitoneal Chemotherapy 6Fluorodeoxyglucose F18 6Cytoreduction Surgical Procedures 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Practice Guidelines as Topic × Gynecologic × Clear all
NCT03641287 2023-11-29

The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors

University of Washington

Phase NA Terminated
64 enrolled 16 charts
Gynecologic

Brenner Tumor, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡